Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Hemoglobin C disease (HbC) is a hemoglobinopathy characterized by production of abnormal variant hemoglobin known as hemoglobin C, with no or mild clinical manifestations (hemolytic anemia).
Biomarker and diagnostic research for hemoglobin C disease has been reported in the published literature.
No clinical trials have been registered for hemoglobin C disease.
10 publications have been identified in PubMed for hemoglobin C disease. Research spans Epidemiology / Natural History (40%), Diagnostic / Biomarker (20%), and Case Report / Case Series (20%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 4 | 40% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:47 AM UTC
European rare disease database
2 |
20% |
Patient case studies | 2 | 20% |
Laboratory research | 2 | 20% |
Manjrekar NS (2026). [PMID: 41625049](https://pubmed.ncbi.nlm.nih.gov/41625049/). *Cureus*. [Case Report / Case Series]
Vázquez-Folch SJ (2025). [PMID: 41080369](https://pubmed.ncbi.nlm.nih.gov/41080369/). *Cureus*. [Case Report / Case Series]
Regragui I (2025). [PMID: 40196068](https://pubmed.ncbi.nlm.nih.gov/40196068/). *Cureus*. [Epidemiology / Natural History]
Ruivard M (2025). [PMID: 40930929](https://pubmed.ncbi.nlm.nih.gov/40930929/). *La Revue de medecine interne*. [Epidemiology / Natural History]
Connes P (2025). [PMID: 40625188](https://pubmed.ncbi.nlm.nih.gov/40625188/). *Clinical hemorheology and microcirculation*. [Basic Science / Preclinical]
Xu K (2024). [PMID: 38708168](https://pubmed.ncbi.nlm.nih.gov/38708168/). *Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion*. [Diagnostic / Biomarker]
Aljabry M (2024). [PMID: 38372896](https://pubmed.ncbi.nlm.nih.gov/38372896/). *Journal of epidemiology and global health*. [Basic Science / Preclinical]
Jacobs JW (2024). [PMID: 38291731](https://pubmed.ncbi.nlm.nih.gov/38291731/). *British journal of haematology*. [Epidemiology / Natural History]
Ahmad A (2024). [PMID: 38868813](https://pubmed.ncbi.nlm.nih.gov/38868813/). *International journal of hematology-oncology and stem cell research*. [Epidemiology / Natural History]
Grewal R (2024). [PMID: 38788312](https://pubmed.ncbi.nlm.nih.gov/38788312/). *Bioelectrochemistry (Amsterdam, Netherlands)*. [Diagnostic / Biomarker]